MTVA · MetaVia Inc. · Exempt Offerings
$1.57
+0.03 (+1.90%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Due in large part to the ongoing clinical trials, we expect to continue to incur net losses and negative cash flows from operating activities for the foreseeable future. These conditions raise substantial doubt about our ability to continue as a going concern within one year from the issuance of these unaudited condensed consolidated financial statements.”View the 10-Q filed Aug 6, 2026
Market Cap
$10.94M
Shares
6.59M
Volume · Oct 5
53.09K
Avg daily vol (3M)
234.63K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-05-15 | New | Biotechnology | $10,000,000 | $10,000,000 | 06b |
| 2024-07-01 | New | Biotechnology | $16,998,224 | $16,998,224 | 06b |
| 2021-10-18 | New | Biotechnology | $14,000,002 | $14,000,002 | 06b |
| 2021-02-01 | New | Biotechnology | $10,000,000 | $10,000,000 | 06b |
| 2021-01-12 | New | Biotechnology | $17,030,344 | $17,030,344 | 06b |
Showing 1–5 of 5 filings